1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date – Oct 01, 2019 Product – Zirabev (biosimilar, bevacizumab) The biosimilar was launched in […]readmore
Tags : The Medicines Company
Shots: Novartis to acquire The Medicine Company in all-cash transaction for $85/share at a 24% 1-day premium, making fully diluted equity value as $7.7B and a total deal value as […]readmore